Trial intelligence / Profile preview

Azithromycin as an adjunct to one-stage full mouth disinfection for chronic periodontitis

ACTRN12617000531314Phase 4Completed

Sponsor
The University of Western Australia
Start
Jan 2017
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial in chronic periodontitis comparing OSFD + placebo with OSFD + azithromycin (2 arms). Primary endpoint: Difference in clinical probing pocket depth reduction. Started Jan 2017; status: completed.

02

Drugs

azithromycin
03

Conditions

chronic periodontitis

Beyond the preview

Go deeper on ACTRN12617000531314.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ACTRN12617000531314.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call